Lopinavir and Ritonavir Tablet shortage
To Be Discontinued 4 presentations · 1 manufacturers · first FDA posting Jul 24, 2026 · last update Jul 24, 2026
Manufacturers: AbbVie Inc.
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Kaletra, Tablet, 100 mg; 25 mg (NDC 0074-0522-60) | AbbVie Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Jul 24, 2026 Updated Jul 24, 2026 Discontinued Jul 24, 2026 |
| Kaletra, Tablet, 100 mg; 25 mg (NDC 0074-3008-60) | AbbVie Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Jul 24, 2026 Updated Jul 24, 2026 Discontinued Jul 24, 2026 |
| Kaletra, Tablet, 200 mg; 50 mg (NDC 0074-4014-12) | AbbVie Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Jul 24, 2026 Updated Jul 24, 2026 Discontinued Jul 24, 2026 |
| Kaletra, Tablet, 200 mg; 50 mg (NDC 0074-6799-22) | AbbVie Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Jul 24, 2026 Updated Jul 24, 2026 Discontinued Jul 24, 2026 |